Tomography
Conditions
Keywords
Corneal surgery, Refractive surgery, Biometric parameters, Keratoconus, Dry eye, Laser vision correction
Brief summary
The purpose of this study is to validate the clinical measurement performance of an investigational biometer. Subjects will undergo multiple measurements of the eye, and the agreement, repeatability, and reproducibility of corneal and epithelial thickness maps will be evaluated.
Detailed description
The study population will consist of male and female adult subjects with normal corneas (approximately 30 subjects), keratoconus (approximately 20 subjects), prior corneal laser vision correction (approximately 20 subjects), current and habitual contact lens wear (approximately 20 subjects), and dry eye (approximately 20 subjects). In this single visit study, measurements will be taken by 3 different operators using their own set of devices (configuration), UNITY DX and ANTERION. Each subject's participation is expected to last approximately 3 hours with a planned duration of exposure generally not longer than 10 minutes per device. Only one eye (designated as the study eye) will be enrolled per subject.
Interventions
Investigational non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties
Commercially available non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties
Sponsors
Study design
Eligibility
Inclusion criteria
Key Inclusion Criteria: * Able to understand and sign an Institutional Review Board approved informed consent form. * Willing and able to attend all scheduled study visits as required per protocol. * Identified by the investigator as having normal corneas or abnormal corneas per protocol-specified criteria. * Other protocol-specified inclusion criteria may apply. Key
Exclusion criteria
* Unable to fixate due to nystagmus or other eye movement abnormality, such as significant strabismus. * Any ocular disease and/or condition that, in the investigator's clinical judgement, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study. * Active ocular infection or inflammation. * Other protocol-specified
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean corneal thickness | Day 1 | Corneal thickness will be measured by the device and reported in microns. This outcome measure will be analyzed using Bland-Altman Limits of Agreement, Deming regression, repeatability and reproducibility. |
| Mean epithelial thickness | Day 1 | Epithelial thickness will be measured by the device and reported in microns. This outcome measure will be analyzed using Bland-Altman Limits of Agreement, Deming regression, repeatability and reproducibility. |
Countries
United States
Contacts
Alcon Research, LLC